| Angiomax | dosage | Bivalirudin; Bivalirudin (Medicines Co or MDCO) |
| Angiomax (Medicines Co or MDCO) | dosage | Angiomax; Bivalirudin |
| Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)- | dosage | DAZOXIBEN; Dazoxiben [INN-Spanish]; Dazoxibene [INN-French]; Dazoxibenum [INN-Latin]; Dazoxiben |
| Bivalirudin | Solution (IV Injection and Infusion) | Angiomax; Angiomax (Medicines Co or MDCO) |
| DAZOXIBEN | dosage | Dazoxiben; Dazoxiben [INN-Spanish]; Dazoxibene [INN-French]; Dazoxibenum [INN-Latin]; Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)- |
| Dazoxiben | | DAZOXIBEN; Dazoxiben [INN-Spanish]; Dazoxibene [INN-French]; Dazoxibenum [INN-Latin]; Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)- |
| Dazoxiben [INN-Spanish] | dosage | DAZOXIBEN; Dazoxiben; Dazoxibene [INN-French]; Dazoxibenum [INN-Latin]; Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)- |
| Dazoxibene [INN-French] | dosage | DAZOXIBEN; Dazoxiben [INN-Spanish]; Dazoxiben; Dazoxibenum [INN-Latin]; Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)- |
| Dazoxibenum [INN-Latin] | dosage | DAZOXIBEN; Dazoxiben [INN-Spanish]; Dazoxibene [INN-French]; Dazoxiben; Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)- |
| Hirudin variant-1 | dosage | Lepirudin; Refludan (Berlex Labs) |
| Lepirudin | Powder for solution; Solution (IV infusion and injection) | Hirudin variant-1; Refludan (Berlex Labs) |
| Norglycin | dosage | Treprostinil; Tolanase; Tolinase |
| Refludan (Berlex Labs) | dosage | Hirudin variant-1; Lepirudin |
| Tolanase | dosage | Norglycin; Treprostinil; Tolinase |
| Tolinase | dosage | Norglycin; Tolanase; Treprostinil |
| Treprostinil | Solution for injection (supplied in 20 mL multi-use vials in four strengths, containing 1 mg/mL, 2.5 mg/mL, 5 mg/mL or 10 mg/mL of treprostinil) | Norglycin; Tolanase; Tolinase |